Cardiovascular profile and retinopathy in a cohort of diabetic patients: a real-world retrospective study

Authors

DOI:

https://doi.org/10.29352/mill0230.47388

Keywords:

diabetic retinopathy; hypertension; dyslipidemia; cardiovascular risk

Abstract

Introduction: Diabetic retinopathy (DR) is one of the main microvascular complications of diabetes mellitus (DM) and a significant cause of visual impairment. In addition to chronic hyperglycemia, cardiovascular risk factors such as arterial hypertension (HTN) and dyslipidemia may influence its development and progression. Assessing the cardiovascular profile in people with diabetes can improve our understanding of the factors associated with RD and contribute to more effective preventive strategies.

Objective: To analyze the cardiovascular profile and its association with DR in a cohort of patients with DM.

Methods: A retrospective cross-sectional observational study was conducted in 6,674 patients with DM managed in Primary Care in Ávila between 2010 and 2024. A bivariate analysis was performed to evaluate the association between HTN, dyslipidemia, and DR.

Results: The prevalence of HTN was 70.24%, while dyslipidemia was present in 70.77% of patients. DR was detected in 28.05% of the cohort. HTN was more frequent in patients with DR compared to those without DR, whereas dyslipidemia showed a homogeneous distribution between groups.

Conclusion: DR showed a high prevalence in the studied cohort. HTN was associated with the presence of DR, whereas dyslipidemia showed no differences between groups.

Downloads

Download data is not yet available.

References

Bosch, X., Alfonso, F., & Bermejo, J. (2002). Diabetes and cardiovascular disease: A comprehensive insight to the new epidemic of the 21st century. Revista Española de Cardiología, 55(5), 525–527. https://doi.org/10.1016/s0300-8932(02)76645-1

Castell, C., Goday, A., Mata-Cases, M., Jando, C., Vlacho, B., Real, J., Guarga, A., Medina, M., & Franch-Nadal, J. (2022). Evolución de la prevalencia, incidencia y control metabólico de la diabetes tipo 2 en España: Datos poblacionales recientes. Avances en Diabetología / Endocrinología, Diabetes y Nutrición, 69(3), 212–220. https://doi.org/10.1016/j.endinu.2022.03.004

Cebrián-Cuenca, A. M., Mata-Cases, M., Franch-Nadal, J., Salvador-González, B., Kundu, S., & Mauricio, D. (2021). Quality of care and primary care screening strategies for diabetic retinopathy in Spain. Primary Care Diabetes, 15(4), 675–682. https://doi.org/10.1016/j.pcd.2021.04.008

Cheloni, R., Gandolfi, S. A., & Burroughs, M. (2025). Automated screening and predictive modeling for microvascular complications in primary care: A longitudinal cohort evaluation. British Journal of Ophthalmology, 109(3), 341–349. https://doi.org/10.1136/bjo-2024-325678

ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. S., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., ... on behalf of the American Diabetes Association. (2023). Retinopathy, neuropathy, and foot care: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S203–S215. https://doi.org/10.2337/dc23-S012

ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. S., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., ... on behalf of the American Diabetes Association. (2024). Cardiovascular disease and risk management: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S179–S218. https://doi.org/10.2337/dc24-S010

Kang, E. Y., Chen, T. H., Garg, S. J., Canner, J. K., Yeung, L., Wu, W. C., & Lai, C. C. (2019). Association of statin therapy with prevention of vision-threatening diabetic retinopathy. JAMA Ophthalmology, 137(4), 363–371. https://doi.org/10.1001/jamaophthalmol.2018.6399

Klein, R., Klein, B. E., Moss, S. E., Davis, M. D., & DeMets, D. L. (1984). The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology, 102(4), 520–526. https://doi.org/10.1001/archopht.1984.01040030402011

Romero-Aroca, P., López-Gálvez, M., Martínez-Brocca, M. A., Pareja-Ríos, A., Artola, S., & Franch-Nadal, J. (2022). Changes in the epidemiology of diabetic retinopathy in Spain: A systematic review and meta-analysis. Healthcare, 10(7), Article 1318. https://doi.org/10.3390/healthcare10071318

Siguier, M., & Guillausseau, P. J. (2021). Lipid-lowering therapy and diabetic retinopathy: What is the evidence in real-world clinical practice? European Journal of Ophthalmology, 31(4), 1620–1629. https://doi.org/10.1177/11206721211004631

Simó, R., & Hernández, C. (2019). Complicaciones crónicas de la diabetes mellitus: retinopatías y otros problemas oculares. En Sociedad Española de Endocrinología y Nutrición (Ed.). Manual de endocrinología y nutrición (pp. 415–428). SEEN. https://doi.org/10.3221/seen.manual.2019.034

Solomon, S. D., Chew, E., Duh, E. J., Sobrin, L., Sun, J. K., VanderBeek, B. L., & on behalf of the American Diabetes Association. (2017). Diabetic retinopathy: A position statement by the American Diabetes Association. Diabetes Care, 40(3), 412–418. https://doi.org/10.2337/dc16-2641

Soriguer, F., Goday, A., Bosch-Comas, A., Bordiú, E., Calle-Pascual, A., Carmena, R., Casamitjana, R., Castaño, L., Castell, C., Catalá, M., Delgado, E., Franch, J., Gaztambide, S., Girbés, J., Gomis, R., Gutiérrez, G., López-Alba, A., Martínez-Larrad, M. T., Menéndez, E., ... Rojo-Martínez, G. (2012). Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study. Diabetologia, 55(1), 88–93. https://doi.org/10.1007/s00125-011-2336-9

Suárez Pita, D., Vargas Romero, J. C., Salas Jarque, J., Losada Galván, I., de Miguel Campo, B., & Catalán Martín, P. M. (Eds.). (2016). Manual de diagnóstico y terapéutica médica (8.ª ed., pp. 1241–1287). Hospital Universitario 12 de Octubre.

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Magliano, D. J., & Boyko, E. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, Article 109119. https://doi.org/10.1016/j.diabres.2021.109119

Teo, Z. L., Tham, Y. C., Yu, M., Chee, M. L., Rim, T. H., Cheung, N., Yeo, C. H., Tan, G. S. W., Ting, D. S. W., Cheng, C. Y., Wang, J. J., Wong, T. Y., & Cheng, C. Y. (2021). Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology, 128(11), 1580–1591. https://doi.org/10.1016/j.ophtha.2021.04.027

Ting, D. S. W., Carin, L., & Wong, T. Y. (2024). Digital technology, artificial intelligence, and big data in ophthalmology: Present and future perspectives. The Lancet Digital Health, 6(2), e132–e144. https://doi.org/10.1016/S2589-7500(23)00224-1

UK Prospective Diabetes Study Group. (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317(7160), 703–713. https://doi.org/10.1136/bmj.317.7160.703

Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., Haffner, S., Hamman, R. F., Ikram, M. K., Kayama, T., Klein, B. E. K., Klein, R., Krishnaiah, S., Mayurasakorn, K., O’Hare, J. P., ... Shaw, J. (2012). Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 35(3), 556–564. https://doi.org/10.2337/dc11-1909

Published

2026-07-02

How to Cite

Martín González, J., Alonso Moro, D., García Criado, F. J., & Corchado, J. M. (2026). Cardiovascular profile and retinopathy in a cohort of diabetic patients: a real-world retrospective study. Millenium - Journal of Education, Technologies, and Health, 2(30), e47388. https://doi.org/10.29352/mill0230.47388

Issue

Section

Life and Healthcare Sciences